Suchergebnisse - "Yusenko, Maria"

PubPharm (53)

11

Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma - a short report

enthalten in: Cellular oncology | 2021

von Beres, B. | Yusenko, M. | Peterfi, L. | +2

12

Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma - a short report

enthalten in: Cellular oncology | 2021

von Beres, B. | Yusenko, M. | Peterfi, L. | +2

13

Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner

enthalten in: Cancer letters | 2021

von Yusenko, M. | Biyanee, A. | Andersson, M. | +4

14

Expression of TXNIP is associated with angiogenesis and postoperative relapse of conventional renal cell carcinoma

enthalten in: Scientific reports | 2021

von Meszaros, M. | Yusenko, M. | Domonkos, L. | +3

15

C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia

enthalten in: Oncogene | 2021

von Yusenko, M. | Trentmann, A. | Casolari, D. | +13

16

The Role of Genetic Analysis in Correct Diagnosis of Eosinophilic Variant of Chromophobe Renal Cell Carcinoma

enthalten in: Anticancer research | 2020

von Molnar, A. | Yusenko, M. | Kovacs, G. | +1

17

Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma

enthalten in: British journal of cancer | 2020

von Peterfi, L. | Banyai, D. | Yusenko, M. | +2

18

Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells

enthalten in: Cancer letters | 2020

von Yusenko, M. | Trentmann, A. | Andersson, M. | +7

19

Cytoplasmic Expression of AXL Is Associated With High Risk of Postoperative Relapse of Conventional Renal Cell Carcinoma

enthalten in: Anticancer research | 2020

von Peterfi, L. | Bjercke, T. | Yusenko, M. | +2

20

Cytoplasmic expression of AXL is associated with high risk of postoperative relapse of conventional renal cell carcinoma

enthalten in: Anticancer research | Jun 2020

von Peterfi, L. | Bjercke, T. | Yusenko, M. | +2